(Q39678480)

13 September 2017

title

Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia (English)

1 reference

13 September 2017

5

Felix Zintl

1 reference

13 September 2017

Martin Benesch

1

1 reference

13 September 2017

Christian Urban

2

1 reference

13 September 2017

Karl W Sykora

3

1 reference

13 September 2017

Wolfgang Schwinger

4

1 reference

13 September 2017

Herwig Lackner

6

1 reference

13 September 2017

Peter Lang

7

1 reference

13 September 2017

Rupert Handgretinger

8

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

British Journal of Haematology

13 September 2017

published in

1 reference

13 September 2017

volume

125

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

58-63

1 reference

The modern management of severe aplastic anaemia

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04857.X

10.1111/J.1365-2141.2004.04857.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference